Presentation is loading. Please wait.

Presentation is loading. Please wait.

Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.

Published byAntony Gordon Modified over 6 years ago

Similar presentations

Presentation on theme: "Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA."— Presentation transcript:

1 Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA

2 The child asthma report only concerns patients aged ≤ 17 years
Practice Overview The child asthma report only concerns patients aged ≤ 17 years Asthma Patient: asthma QOF diagnosis code & no asthma resolved code & issued respiratory therapy in last 2 years Page 1

3 Contents Patient Demographics Asthma Diagnosis Asthma Control
Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 2

4 Age Distribution Co-morbidities Smoking Status Patient Demographics
Contents Patient Demographics Age Distribution Co-morbidities Smoking Status Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 3

5 The child asthma report only concerns patients aged ≤ 17 years
Patient Demographics Age Distribution The child asthma report only concerns patients aged ≤ 17 years Page 4

6 Co-morbidities Patient Demographics Page 5
Rhinitis: Read code entry in last 2 years or nasal steroid therapy in last year GERD, Depression/Anxiety: Read code entry in last 2 years Page 5

7 Smoking Status Patient Demographics Page 6
Smoking status is obtained from patient questionnaires where available or from routine practice data Page 6

8 Confirming Asthma Diagnosis Potentially Undiagnosed Patients
Contents Patient Demographics Asthma Diagnosis Confirming Asthma Diagnosis Potentially Undiagnosed Patients Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 7

9 Confirming Asthma Diagnosis
Asthma Diagnosis: asthma QOF diagnosis code Excluding Patients ≤ age 7 years: QOF AST002 Page 8

10 Potentially Undiagnosed Patients
Asthma Diagnosis Potentially Undiagnosed Patients LRTIs: measured as occurrence of 3 or more LRTIs in last 2 years Asthma Diagnosis: asthma QOF diagnosis code Page 9

11 Control Status from RCP Data, SABA use, etc
Contents Patient Demographics Asthma Diagnosis Asthma Control Control Status from RCP Data, SABA use, etc Smoking, Rhinitis and Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 10

12 Measuring Asthma Control
Information from three sources is used to assess patients’ asthma GINA control score* and other measures of asthma control: Practice recorded data from RCP3 questions, ACT questions, reliever use and PEFR. Data from patient questionnaire responses: RCP3 questions, reliever use, etc. Quantity of SABA prescriptions, which can be used as proxy measure of asthma control. Global INitiative for Asthma (GINA) control score can be calculated from RCP3 questions responses, reliever use and lung function data Page 11

13 Asthma Control Status: RCP Data*
RCP data is obtained from patient questionnaires where available or from routine practice data Page 12

14 Asthma Control Status: SABA as Proxy*
Where RCP Data Unknown Quantity of short acting bronchodilators issued is used as proxy measure of asthma control where RCP data is not available Page 13

15 Smoking and Asthma Control*
OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 14

16 Rhinitis and Asthma Control*
OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 15

17 Management by BTS Steps
Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Management by BTS Steps Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 16

18 BTS/SIGN Step Guidelines: Age 13 – 17 Years
Asthma Management BTS/SIGN Step Guidelines: Age 13 – 17 Years Page 17

19 Management by BTS Step: Age 13 – 17 Years
Asthma Management Management by BTS Step: Age 13 – 17 Years Page 18

20 BTS/SIGN Step Guidelines: Age 5 – 12 Years
Asthma Management BTS/SIGN Step Guidelines: Age 5 – 12 Years Page 19

21 Management by BTS Step: Age 5 – 12 Years
Asthma Management Management by BTS Step: Age 5 – 12 Years Page 20

22 BTS/SIGN Step Guidelines: Age Under 5 Years
Asthma Management BTS/SIGN Step Guidelines: Age Under 5 Years Page 21

23 Management by BTS Step: Age Under 5 Years
Asthma Management Management by BTS Step: Age Under 5 Years Page 22

24 Asthma Control by BTS Step: RCP Data*
Asthma Management Asthma Control by BTS Step: RCP Data* OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 23

25 Asthma Control by BTS Step: SABA Proxy*
Asthma Management Asthma Control by BTS Step: SABA Proxy* OPC Service Quantity of short acting bronchodilators issued is used as proxy measure of asthma control where RCP data is not available Page 24

26 High Risk Patients Exacerbations Patient Demographics Asthma Diagnosis
Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations High Risk Patients Exacerbations Adherence and Asthma Reviews Recommendations Page 25

27 High Risk Asthma Patients
Risk and Exacerbations High Risk Asthma Patients High Risk: 2 or more exacerbations per year Very High Risk: 2 or more exacerbations per year & at BTS Step 4 or 5 Page 26

28 Exacerbation* by BTS Step
Risk and Exacerbations Exacerbation* by BTS Step OPC Service Exacerbations: exacerbation Read code entry or patient reported exacerbation & hospitalisations & number of courses of oral steroids in last 12 months Page 27

29 Acute Oral Steroid Use* by BTS Step
Risk and Exacerbations Acute Oral Steroid Use* by BTS Step OPC Service Courses of acute oral steroids issued in the last 12 months Page 28

30 Adherence to Inhaled Steroids Inhaler Technique Asthma Reviews
Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Adherence to Inhaled Steroids Inhaler Technique Asthma Reviews Recommendations Page 29

31 Adherence to Inhaled Steroids*
Adherence and Asthma Reviews Adherence to Inhaled Steroids* Number of scripts in last 1 year Number of scripts expected based on prescribed dosage Adherence = X 100 Inhaled steroids include ICS and combination therapies Page 30

32 Inhaler Technique* and Asthma Control Status
Adherence and Asthma Reviews Inhaler Technique* and Asthma Control Status OPC Service Inhaler technique review provided in last 12 months and recorded by Read code entry Page 31

33 Asthma Reviews and Self-Management Plans*
Adherence and Asthma Reviews Asthma Reviews and Self-Management Plans* Asthma reviews and self-management plans provided in last 12 months and recorded by Read code entry Page 32

34 Asthma Reviews by BTS Step
Adherence and Asthma Reviews Asthma Reviews by BTS Step Asthma reviews provided in last 12 months and recorded by Read code entry Page 33

35 Therapy Recommendations Management Recommendations
Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Therapy Recommendations Management Recommendations Page 34

36 PLEASE NOTE Recommendations
The practice report recommendations have been grouped into ‘Therapy Recommendations’ and ‘Management Recommendations’. Please consider both groups of recommendations together, as a holistic approach is vital for effective patient care and optimising patient outcomes. Patients covered within each recommendation and the patient questionnaire responses can be viewed on your asthma patient level reports, through the OPC Tools application on your practice computer. Please refer to the ‘Viewing Patient Reports’ user-guide to assist you in this regard. Alternatively, please contact the OPC service delivery team for assistance. Optimum Patient Care 5 Coles Lane, Oakington, Cambridge, CB24 3BA Tel: Page 35

37 Therapy Recommendations
Please review patient adherence/concordance and inhaler technique before stepping up therapy Adapted from BTS/SIGN and Global Initiative for Asthma (GINA) guidelines Page 36

38 Your Practice Therapy Recommendations
Page 37

39 Management Recommendations
Adapted from BTS/SIGN and Global Initiative for Asthma (GINA) guidelines Page 38

40 Your Practice Management Recommendations
Page 39

Download ppt "Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA."

Similar presentations

Medication Management

Medication Management
What is an asthma registry? n A list of patients with asthma n A source of data for asthma management  individual patient level  individual provider.

What is an asthma registry? n A list of patients with asthma n A source of data for asthma management  individual patient level  individual provider.
Respiratory Care in Children Better Care for Better Outcomes Dr Duncan Keeley GP Thame Thames Valley Strategic Clinical Network.

Respiratory Care in Children Better Care for Better Outcomes Dr Duncan Keeley GP Thame Thames Valley Strategic Clinical Network.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.

2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Nabeela Bari Savitha Pushparajah GP respiratory leads.

Nabeela Bari Savitha Pushparajah GP respiratory leads.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?

Global Initiative for Asthma (GINA) What’s new in GINA 2015?
ELJF-CLINICAL v3.04 Quick 6-step tutorial in under 5 minutes.

ELJF-CLINICAL v3.04 Quick 6-step tutorial in under 5 minutes.
Managing asthma & Inhaler devices for respiratory disease.

Managing asthma & Inhaler devices for respiratory disease.
Clearing the Airways: Innovation in Asthma & Allergy Treatments Chair: Alan Kaplan MD CCFP(EM) FCFP Chair, FPAGC.

Clearing the Airways: Innovation in Asthma & Allergy Treatments Chair: Alan Kaplan MD CCFP(EM) FCFP Chair, FPAGC.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)

Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.

22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.

1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)

Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.

Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.

COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
DDES CCG COPD Project 01/05/15 Dr Dilys Waller Respiratory Nurses - Susan Evison Caroline Blackburn Nichola Lowe Karen Beedle.

DDES CCG COPD Project 01/05/15 Dr Dilys Waller Respiratory Nurses - Susan Evison Caroline Blackburn Nichola Lowe Karen Beedle.
Use of lung function tests in paediatric asthma care A nationwide registry study Grete Moth, MHSc, Ph.D Danish Paediatric Asthma Centre Aarhus University.

Use of lung function tests in paediatric asthma care A nationwide registry study Grete Moth, MHSc, Ph.D Danish Paediatric Asthma Centre Aarhus University.
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:

Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.

History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.

ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.

Similar presentations

Ads by Google